Utilizing Gene Therapy to Induce Long-Term Treatment of Wet AMD & Diabetic Retinopathy
Time: 10:05 am
day: Day One
Details:
- Outline the RGX-314 gene therapy program
- Discussing why suprachoroidal/subretinal delivery are optimal for this treatment
- Reviewing the current clinical data from Phase III clinical trials
